Analyst stock forecast
Intellia Therapeutics Stock Forecast and Analyst Price Target
NTLA analyst target range, upside, consensus rating and coverage count.
Direct answer
Intellia Therapeutics's average price target is $25.94.
The target implies +129.2% from the recorded current price, and the consensus rating is Buy.
The verified range is $8.00 to $95.00, with 17 analysts in the current consensus when available.
Forecast evidence checked August 5, 2026.
Verified data
- Current price
- $11.32
- Average price target
- $25.94
- High price target
- $95.00
- Low price target
- $8.00
- Target upside
- +129.2%
- Consensus rating
- Buy
- Analysts
- 17
- Evidence date
- August 5, 2026
- Valid through
- August 12, 2026